We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Televisa
TV
$1.49B
| $1.3M | 0.01% |
157,800
-30,000
| -16% | -$229K |
|
627
First Trust Consumer Staples AlphaDEX Fund
FXG
$231M
| $1.3M | 0.01% |
25,175
+229
| +0.9% | +$11.6K |
|
628
AstraZeneca
AZN
$250B
| $1.29M | 0.01% |
12,965
+3,660
| +39% | +$388K |
|
629
RadNet
RDNT
$5.69B
| $1.29M | 0.01% |
66,200
+12,950
| +24% | +$229K |
|
630
Gorman-Rupp
GRC
$2.21B
| $1.29M | 0.01% |
39,928
+14,495
| +57% | +$480K |
|
631
Aurinia Pharmaceuticals
AUPH
$2.11B
| $1.29M | 0.01% |
93,085
-1,000
| -1% | -$14.6K |
|
632
Vanguard FTSE Europe ETF
VGK
$31.1B
| $1.29M | 0.01% |
21,362
+5,617
| +36% | +$316K |
|
633
VictoryShares US 500 Volatility Wtd ETF
CFA
$550M
| $1.28M | 0.01% |
20,608
+893
| +5% | +$52.4K |
|
634
SPDR Gold MiniShares Trust
GLDM
$29.7B
| $1.27M | 0.01% |
33,615
+87
| +0.3% | +$3.25K |
|
635
Zimmer Biomet
ZBH
$18.4B
| $1.25M | 0.01% |
8,366
+1,614
| +24% | +$228K |
|
636
Vanguard Russell 2000 ETF
VTWO
$17.4B
| $1.25M | 0.01% |
15,736
+2,360
| +18% | +$167K |
|
637
T-Mobile US
TMUS
$190B
| $1.24M | 0.01% |
9,209
+4,707
| +105% | +$581K |
|
638
Mettler-Toledo International
MTD
$28.6B
| $1.24M | 0.01% |
1,088
+6
| +0.6% | +$6.58K |
|
639
Quest Diagnostics
DGX
$26.3B
| $1.24M | 0.01% |
10,391
+755
| +8% | +$92K |
|
640
Citizens Financial Group
CFG
$30.6B
| $1.22M | 0.01% |
34,174
+1,070
| +3% | +$33.6K |
|
641
Bio-Rad Laboratories Class A
BIO
$9.42B
| $1.22M | 0.01% |
2,088
+140
| +7% | +$79.7K |
|
642
NetApp
NTAP
$37.2B
| $1.21M | 0.01% |
18,319
-3,859
| -17% | -$204K |
|
643
Brookfield
BN
$108B
| $1.21M | 0.01% |
54,915
+243
| +0.4% | +$4.86K |
|
644
Exelon
EXC
$47B
| $1.21M | 0.01% |
40,128
+8,869
| +28% | +$262K |
|
645
Chipotle Mexican Grill
CMG
$41.5B
| $1.2M | 0.01% |
43,350
+13,250
| +44% | +$348K |
|
646
Corteva
CTVA
$51.3B
| $1.2M | 0.01% |
31,022
+998
| +3% | +$35.7K |
|
647
Global X Silver Miners ETF NEW
SIL
$4.74B
| $1.2M | 0.01% |
26,300
+14,300
| +119% | +$626K |
|
648
Autodesk
ADSK
$52.6B
| $1.19M | 0.01% |
3,895
+2,241
| +135% | +$591K |
|
649
Aon
AON
$76B
| $1.19M | 0.01% |
5,616
+81
| +1% | +$16.5K |
|
650
WEC Energy
WEC
$35.1B
| $1.19M | 0.01% |
12,888
-594
| -4% | -$57.8K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.